Citigroup’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-775
| Closed | -$11.6K | – | 6100 |
|
|
2022
Q4 | $11.6K | Sell |
775
-4,145
| -84% | -$57.4K | ﹤0.01% | 4793 |
|
|
2022
Q3 | $40K | Sell |
4,920
-400
| -8% | -$3.07K | ﹤0.01% | 4494 |
|
|
2022
Q2 | $35K | Buy |
5,320
+3,860
| +264% | +$18.7K | ﹤0.01% | 4709 |
|
|
2022
Q1 | $8K | Buy |
+1,460
| New | +$6.01K | ﹤0.01% | 5664 |
|
|
2021
Q3 | – | Sell |
-24
| Closed | – | – | 6573 |
|
|
2021
Q2 | $0 | Sell |
24
-1,422
| -98% | -$9.8K | ﹤0.01% | 6625 |
|
|
2021
Q1 | $11K | Sell |
1,446
-2,666
| -65% | -$23K | ﹤0.01% | 5614 |
|
|
2020
Q4 | $24K | Buy |
4,112
+3,044
| +285% | +$17.4K | ﹤0.01% | 6547 |
|
|
2020
Q3 | $6K | Sell |
1,068
-718
| -40% | -$3.55K | ﹤0.01% | 6965 |
|
|
2020
Q2 | $9K | Buy |
1,786
+1,766
| +8,830% | +$11.1K | ﹤0.01% | 7122 |
|
|
2020
Q1 | $0 | Sell |
20
-1,775
| -99% | -$8.81K | ﹤0.01% | 7924 |
|
|
2019
Q4 | $12K | Sell |
1,795
-1,240
| -41% | -$9.13K | ﹤0.01% | 7162 |
|
|
2019
Q3 | $25K | Sell |
3,035
-1,016
| -25% | -$7.56K | ﹤0.01% | 6602 |
|
|
2019
Q2 | $27K | Buy |
4,051
+1,229
| +44% | +$10.5K | ﹤0.01% | 6940 |
|
|
2019
Q1 | $23K | Sell |
2,822
-1,184
| -30% | -$12.2K | ﹤0.01% | 6894 |
|
|
2018
Q4 | $64K | Buy |
4,006
+109
| +3% | +$2.4K | ﹤0.01% | 6033 |
|
|
2018
Q3 | $128K | Buy |
3,897
+1,676
| +75% | +$43.1K | ﹤0.01% | 5677 |
|
|
2018
Q2 | $50K | Buy |
2,221
+2,037
| +1,107% | +$48.3K | ﹤0.01% | 6294 |
|
|
2018
Q1 | $5K | Sell |
184
-84
| -31% | -$2.46K | ﹤0.01% | 7229 |
|
|
2017
Q4 | $7K | Buy |
268
+1
| +0.4% | +$31 | ﹤0.01% | 7164 |
|
|
2017
Q3 | $10K | Buy |
267
+176
| +193% | +$5.44K | ﹤0.01% | 6706 |
|
|
2017
Q2 | $2K | Buy |
+91
| New | +$716 | ﹤0.01% | 7074 |
|
|
2016
Q2 | – | Sell |
-29
| Closed | – | – | 7627 |
|
|
2016
Q1 | $0 | Sell |
29
-6
| -17% | -$59 | ﹤0.01% | 7937 |
|
|
2015
Q4 | $0 | Buy |
+35
| New | +$416 | ﹤0.01% | 8025 |
|
|
2015
Q3 | – | Sell |
-36
| Closed | -$1K | – | 7936 |
|
|
2015
Q2 | $1K | Buy |
+36
| New | +$648 | ﹤0.01% | 7392 |
|
|
2015
Q1 | – | Sell |
-100
| Closed | -$1K | – | 7561 |
|
|
2014
Q4 | $1K | Buy |
100
+67
| +203% | +$613 | ﹤0.01% | 7025 |
|
|
2014
Q3 | $0 | Sell |
33
-123
| -79% | -$1.56K | ﹤0.01% | 7417 |
|
|
2014
Q2 | $3K | Sell |
156
-3,781
| -96% | -$49.2K | ﹤0.01% | 6673 |
|
|
2014
Q1 | $59K | Buy |
3,937
+1,907
| +94% | +$34.3K | ﹤0.01% | 5389 |
|
|
2013
Q4 | $37K | Buy |
2,030
+48
| +2% | +$961 | ﹤0.01% | 5870 |
|
|
2013
Q3 | $41K | Sell |
1,982
-312
| -14% | -$7.14K | ﹤0.01% | 5427 |
|
|
2013
Q2 | $58K | Buy |
+2,294
| New | +$98.1K | ﹤0.01% | 5280 |
|
Citigroup's AVEO Position: Q1 2023 in Review
Citigroup sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 775 shares — an estimated $11.6K sold.
Citigroup first reported a position in AVEO in Q2 2013 and held it in 31 quarters. The position peaked at $128K in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Citigroup reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Citigroup sold 775 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $11.6K.
- Citigroup first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 31 quarters.
- Citigroup's AVEO Pharmaceuticals, Inc. position peaked at $128K in Q3 2018.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Citigroup's 13F filing for Q1 2023, filed 11 May 2023.